Sorrentino Ugo, Boesch Sylvia, Doummar Diane, Ravelli Claudia, Serranova Tereza, Indelicato Elisabetta, Winkelmann Juliane, Burglen Lydie, Jech Robert, Zech Michael
Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
J Neurol. 2024 May;271(5):2859-2865. doi: 10.1007/s00415-024-12271-x. Epub 2024 Mar 5.
Heterozygous loss-of-function variants in CHD8 have been associated with a syndromic neurodevelopmental-disease spectrum, collectively referred to as CHD8-related neurodevelopmental disorders. Several different clinical manifestations, affecting neurodevelopmental and systemic domains, have been described, presenting with highly variable expressivity. Some expressions are well established and comprise autism spectrum disorders, psychomotor delay with cognitive impairment, postnatal overgrowth with macrocephaly, structural brain abnormalities, gastrointestinal disturbances, and behavioral and sleep-pattern problems. However, the complete phenotypic spectrum of CHD8-related disorders is still undefined. In 2021, our group described two singular female patients with CHD8-related neurodevelopmental disorder and striking dystonic manifestations, prompting the suggestion that dystonia should be considered a possible component of this condition.
We describe three additional unrelated female individuals, each carrying a different CHD8 frameshift variant and whose clinical presentations were primarily characterized by young-onset dystonia. Their dystonic manifestations were remarkably heterogeneous and ranged from focal, exercise-dependent, apparently isolated forms to generalized permanent phenotypes accompanied by spasticity and tremor. Neurocognitive impairment and autistic behaviors, typical of CHD8-related disorders, were virtually absent or at the mild end of the spectrum.
This work validates our previous observation that dystonia is part of the phenotypic spectrum of CHD8-related neurodevelopmental disorders with potential female preponderance, raising new challenges and opportunities in the diagnosis and management of this condition. It also highlights the importance of in-depth neurologic phenotyping of patients carrying variants associated with neurodevelopmental disorders, as the connection between neurodevelopmental and movement disorders is proving closer than previously appreciated.
CHD8基因的杂合功能丧失变异与一系列综合征性神经发育疾病相关,统称为CHD8相关神经发育障碍。已经描述了几种不同的临床表现,涉及神经发育和全身领域,表现出高度可变的表达性。一些表现已得到充分证实,包括自闭症谱系障碍、伴有认知障碍的精神运动发育迟缓、出生后过度生长伴巨头畸形、结构性脑异常、胃肠道紊乱以及行为和睡眠模式问题。然而,CHD8相关疾病的完整表型谱仍不明确。2021年,我们的团队描述了两名患有CHD8相关神经发育障碍且有明显肌张力障碍表现的独特女性患者,这提示肌张力障碍应被视为这种疾病的可能组成部分。
我们描述了另外三名无亲缘关系的女性个体,她们各自携带不同的CHD8移码变异,临床表现主要以早发性肌张力障碍为特征。她们的肌张力障碍表现非常异质,范围从局灶性、运动依赖性、明显孤立的形式到伴有痉挛和震颤的全身性永久性表型。CHD8相关疾病典型的神经认知障碍和自闭症行为实际上不存在或处于谱系的轻度端。
这项工作证实了我们之前的观察结果,即肌张力障碍是CHD8相关神经发育障碍表型谱的一部分,可能在女性中更为常见,这给这种疾病的诊断和管理带来了新的挑战和机遇。它还强调了对携带与神经发育障碍相关变异的患者进行深入神经表型分析的重要性,因为神经发育障碍和运动障碍之间的联系比以前认为的更为紧密。